Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
CARTITUDE-4 Update: Cilta-Cel Improves OS in R/R MM
RIO DE JANEIRO — A single infusion of the chimeric antigen receptor (CAR) T-cell therapy ciltacabtagene autoleucel, or cilta-cel (CARVYKTI, Janssen Biotech, Inc.), reduces the risk for death by 45% vs standard-of-care (SoC) therapies in patients with lenalidomide-refractory multiple myeloma,…
English